Castle TissueCypher Surpasses 100,000 Orders in Barrett’s
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
BASEL, Switzerland, June 12, 2026 Novartis announced new Phase III data at the European Academy of Allergy and Clinical...
BOSTON and SHENZHEN, China, June 10, 2026 XtalPi, a global leader in AI and robotics-driven drug discovery, has announced...
EAGAN, Minn., June 9, 2026 Sonex Health, Inc. and The Institute of Advanced Ultrasound Guided Procedures have announced the...
MENLO PARK, Calif., June 10, 2026 Subtle Medical has received U.S. FDA clearance for SubtleHDâ„¢(CT), a new artificial intelligence-powered...
AMSTERDAM, Netherlands, June 9, 2026 Artificial intelligence is already delivering measurable benefits across healthcare systems, saving clinicians the equivalent...
BERLIN, Germany, June 10, 2026 Vara has received CE Class IIb certification under the European Union Medical Device Regulation...
